These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 1404451)

  • 1. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen therapy for breast cancer and endometrial cancer risk.
    Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
    J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral contraceptives, alcohol, and risk for invasive breast cancer.
    Dumeaux V; Lund E; Hjartåker A
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1302-7. PubMed ID: 15298950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer.
    McClain KM; McCullough LE; Bradshaw PT; Shantakumar S; Terry MB; Neugut AI; Gammon MD
    J Womens Health (Larchmt); 2017 Nov; 26(11):1176-1184. PubMed ID: 28384095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.
    Cantwell MM; Lacey JV; Schairer C; Schatzkin A; Michaud DS
    Int J Cancer; 2006 Nov; 119(10):2398-401. PubMed ID: 16894568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status.
    Hvidtfeldt UA; Tjønneland A; Keiding N; Lange T; Andersen I; Sørensen TI; Prescott E; Hansen ÅM; Grønbæk M; Bojesen SE; Diderichsen F; Rod NH
    Epidemiology; 2015 May; 26(3):353-61. PubMed ID: 25695354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk and the interaction between adolescent body size and weight gain in later life: A case-control study.
    Florath I; Sarink D; Saunders C; Heyworth J; Fritschi L
    Cancer Epidemiol; 2016 Dec; 45():135-144. PubMed ID: 27810485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer and alcohol consumption. A study in weak associations.
    Harris RE; Wynder EL
    JAMA; 1988 May; 259(19):2867-71. PubMed ID: 3367453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult weight change and risk of postmenopausal breast cancer.
    Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
    JAMA; 2006 Jul; 296(2):193-201. PubMed ID: 16835425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
    Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
    Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.
    van Leeuwen FE; Rookus MA
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1961-72. PubMed ID: 2698811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.